Commerce Department Authorizes PCI Pharma Services' FTZ Production in Pennsylvania
March 26, 2025
March 26, 2025
WASHINGTON, March 26 (TNSFR) -- The U.S. Department of Commerce Foreign-Trade Zones (FTZ) Board has authorized production activity for PCI Pharma Services at its facilities in Croydon and Philadelphia, Pennsylvania.
The approval, announced on March 26, 2025, allows PCI Pharma Services to conduct specific manufacturing operations within Subzone 35L under FTZ procedures. This designation could provide the company with certain tariff-related benefits when using foreign materials in its . . .
The approval, announced on March 26, 2025, allows PCI Pharma Services to conduct specific manufacturing operations within Subzone 35L under FTZ procedures. This designation could provide the company with certain tariff-related benefits when using foreign materials in its . . .